Matthijs Glastra - Novanta CEO Chairman
| NOVT Stock | USD 169.79 5.07 3.08% |
Chairman
Mr. Matthijs Glastra serves as Chief Executive Officer, Director of the company. He joined Novanta Inc. in 2012 as Group President, and was appointed the Companys Chief Operating Officer in February 2015. Prior to Novanta, he led and grew global technology businesses in advanced industrial and medical endmarkets during an 18year career with Philips, both in Europe and in Silicon Valley. At Philips, he served as Chief Executive Officer of Philips Entertainment Lighting in 2012 and as Chief Operating Officer of Philips Lumileds from 2007 to 2012. Prior to that, he held multiple General Manager and Vice President positions at the Philips Healthcare, Semiconductor and Lighting divisions from 1994 to 2007. He also served as Director of Corporationrationrate Strategy in the Philips corporate headquarters. Mr. Glastra holds a MS Degree in Applied Physics from Delft University of Technology, an Advanced Engineering Degree from ESPCI in Paris, France, and an MBA from INSEAD in Fontainebleau, France since 2016.
| Age | 55 |
| Tenure | 8 years |
| Address | 125 Middlesex Turnpike, Bedford, MA, United States, 01730 |
| Phone | 781 266 5700 |
| Web | https://www.novanta.com |
Latest Insider Transactions
Glastra’s 25 years of leadership and executive operating experience in Original Equipment Manufacturer based technology businesses in advanced industrial and medical end markets, and his intimate knowledge of the Company’s businesses provide valuable insight to the Board in formulating and executing the Company strategy.Matthijs Glastra Latest Insider Activity
Tracking and analyzing the buying and selling activities of Matthijs Glastra against Novanta stock is an integral part of due diligence when investing in Novanta. Matthijs Glastra insider activity provides valuable insight into whether Novanta is net buyers or sellers over its current business cycle. Note, Novanta insiders must abide by specific rules, including filing SEC forms every time they buy or sell Novanta'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Matthijs Glastra over a week ago Disposition of 900 shares by Matthijs Glastra of Novanta at 183.16 subject to Rule 16b-3 | ||
Matthijs Glastra over two months ago Disposition of 19572 shares by Matthijs Glastra of Novanta subject to Rule 16b-3 | ||
Matthijs Glastra over three months ago Disposition of 14 shares by Matthijs Glastra of Novanta at 160.05 subject to Rule 16b-3 | ||
Matthijs Glastra over three months ago Disposition of tradable shares by Matthijs Glastra of Novanta at 163.11 subject to Rule 16b-3 |
Novanta Management Efficiency
The company has return on total asset (ROA) of 0.0535 % which means that it generated a profit of $0.0535 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0867 %, meaning that it created $0.0867 on every $100 dollars invested by stockholders. Novanta's management efficiency ratios could be used to measure how well Novanta manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.13 in 2024. Return On Capital Employed is likely to gain to 0.11 in 2024. At this time, Novanta's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 434.1 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 106.1 M in 2024.Similar Executives
| Found 3 records | CHAIRMAN Age | ||
| David Gandini | Sobr Safe | 66 | |
| Alan Spoon | Fortive Corp | 68 | |
| Victor Richey | ESCO Technologies | 67 | |
Management Performance
| Return On Equity | 0.0867 | ||||
| Return On Asset | 0.0535 |
Novanta Leadership Team
Elected by the shareholders, the Novanta's board of directors comprises two types of representatives: Novanta inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Novanta. The board's role is to monitor Novanta's management team and ensure that shareholders' interests are well served. Novanta's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Novanta's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ray Nash, Corporate IR | ||
| Matthijs Glastra, CEO Chairman | ||
| Michele Welsh, General Secretary | ||
| Sarah Betadam, Chief Officer | ||
| John II, Chief Controller | ||
| Heinrich Dreyer, Group Solutions | ||
| Anna Fain, Equity Diversity | ||
| Chuck Ravetto, Group Group | ||
| Robert Buckley, Chief Officer | ||
| Peter Chang, Corporate Officer | ||
| Brian Young, Chief Human Resource Officer | ||
| Charlie Webster, Executive Chain |
Novanta Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Novanta a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0867 | ||||
| Return On Asset | 0.0535 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 6.52 B | ||||
| Shares Outstanding | 35.92 M | ||||
| Shares Owned By Insiders | 0.87 % | ||||
| Shares Owned By Institutions | 99.13 % | ||||
| Number Of Shares Shorted | 1.71 M | ||||
| Price To Earning | 126.20 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Novanta Stock Analysis
When running Novanta's price analysis, check to measure Novanta's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novanta is operating at the current time. Most of Novanta's value examination focuses on studying past and present price action to predict the probability of Novanta's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novanta's price. Additionally, you may evaluate how the addition of Novanta to your portfolios can decrease your overall portfolio volatility.